Janus Henderson Group’s ESSA Pharma EPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,006,202
| Closed | -$5.19M | – | 2538 |
|
|
2024
Q2 | $5.19M | Sell |
1,006,202
-169,040
| -14% | -$872K | ﹤0.01% | 833 |
|
|
2024
Q1 | $9.98M | Buy |
1,175,242
+85,760
| +8% | +$728K | 0.01% | 693 |
|
|
2023
Q4 | $7.13M | Buy |
+1,089,482
| New | +$7.13M | ﹤0.01% | 727 |
|
|
2022
Q3 | – | Sell |
-2,909,410
| Closed | -$9.17M | – | 2563 |
|
|
2022
Q2 | $9.17M | Sell |
2,909,410
-563,390
| -16% | -$1.78M | 0.01% | 713 |
|
|
2022
Q1 | $21.5M | Buy |
3,472,800
+68,093
| +2% | +$421K | 0.01% | 731 |
|
|
2021
Q4 | $48.3M | Sell |
3,404,707
-73,137
| -2% | -$1.04M | 0.02% | 557 |
|
|
2021
Q3 | $27.8M | Buy |
3,477,844
+1,459,950
| +72% | +$11.7M | 0.01% | 710 |
|
|
2021
Q2 | $57.7M | Buy |
2,017,894
+501,792
| +33% | +$14.3M | 0.02% | 532 |
|
|
2021
Q1 | $44M | Buy |
1,516,102
+1,007,007
| +198% | +$29.2M | 0.02% | 585 |
|
|
2020
Q4 | $6M | Buy |
509,095
+33,407
| +7% | +$393K | ﹤0.01% | 931 |
|
|
2020
Q3 | $3.26M | Buy |
475,688
+74,092
| +18% | +$507K | ﹤0.01% | 981 |
|
|
2020
Q2 | $2.46M | Buy |
401,596
+202,797
| +102% | +$1.24M | ﹤0.01% | 1004 |
|
|
2020
Q1 | $796K | Buy |
+198,799
| New | +$796K | ﹤0.01% | 1129 |
|